Seon Kinrot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seon Kinrot has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Donghoon Lee
Icahn School of Medicine at Mount Sinai
5 shared publications - Gabriel E. Hoffman
Icahn School of Medicine at Mount Sinai
5 shared publications - Jaroslav Bendl
Icahn School of Medicine at Mount Sinai
5 shared publications - John F. Fullard
Icahn School of Medicine at Mount Sinai
5 shared publications - Panos Roussos
Icahn School of Medicine at Mount Sinai
5 shared publications - Vahram Haroutunian
Mount Sinai and JJ Peters VA Medical Center
4 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Springer Nature in Research Square
Coordinated cellular responses track cognitive outcomes in Alzheimer’s disease
Individuals with comparable Alzheimer’s disease (AD) pathology can differ markedly in cognition, but the molecular nature of this heterogeneity remains unclear. Here we profiled paired gene expression and chromatin accessibility in 1.42 million nuclei from three cortical regions of 247 donors. A pathology-supervised transcriptomic score, supported by paired chromatin measurements, resolved cellular disease state differences within samples and between individuals. After adjustment for measured pathology, cellular responses were concordant across major cell classes and cortical regions. Higher pathology-adjusted responses were associated with lower relative abundance of vulnerable excitatory and somatostatin-expressing inhibitory neurons and poorer cognitive outcomes. Pathology-associated, pathology-adjusted, and within-sample cellular-state differences converged on overlapping molecular programs. Unsupervised analysis identified reproducible donor-associated transcriptional programs, including a proteostasis and cellular-stress program associated with higher pathology-adjusted responses, contrasting a lipid-metabolic and biosynthetic program showing the opposite relationship across regions and cohorts. Together, these findings identify a coordinated molecular phenotype associated with differences in neuronal composition and cognition among individuals with comparable measured neuropathology.
- 20 October 2026
- Published by Springer Nature in Research Square
Open AccessCoordinated cellular responses track cognitive outcomes in Alzheimer’s disease
Individuals with comparable Alzheimer’s disease (AD) pathology can differ markedly in cognition, but the molecular nature of this heterogeneity remains unclear. Here we profiled paired gene expression and chromatin accessibility in 1.42 million nuclei from three cortical regions of 247 donors. A pathology-supervised transcriptomic score, supported by paired chromatin measurements, resolved cellular disease state differences within samples and between individuals. After adjustment for measured pathology, cellular responses were concordant across major cell classes and cortical regions. Higher pathology-adjusted responses were associated with lower relative abundance of vulnerable excitatory and somatostatin-expressing inhibitory neurons and poorer cognitive outcomes. Pathology-associated, pathology-adjusted, and within-sample cellular-state differences converged on overlapping molecular programs. Unsupervised analysis identified reproducible donor-associated transcriptional programs, including a proteostasis and cellular-stress program associated with higher pathology-adjusted responses, contrasting a lipid-metabolic and biosynthetic program showing the opposite relationship across regions and cohorts. Together, these findings identify a coordinated molecular phenotype associated with differences in neuronal composition and cognition among individuals with comparable measured neuropathology.
- Open Access
- 7 October 2026
- Published by Springer Nature in Research Square
Cell-type-resolved mRNA 3′-end remodeling in Alzheimer’s disease
Alternative polyadenylation diversifies messenger RNAs by altering coding sequences and 3′ untranslated regions, but its organization across human brain cell types and disruption in neurodegeneration remain poorly understood. By analyzing 3′-capture single-nucleus RNA sequencing data of 6.3 million nuclei from the prefrontal cortex of 1,494 human donors, we defined 108,768 polyadenylation sites across 25,274 genes, most of which were absent from the GENCODE polyadenylation-site annotation. Polyadenylation-site usage was strongly cell-type-specific and revealed regulatory differences not captured by gene expression. With increasing Alzheimer’s disease clinicopathological severity, excitatory neurons, oligodendrocytes and immune cells showed increased distal-site preference, including reduced relative usage of intronic sites and increased distal 3′ untranslated region usage in synaptic and RNA-processing genes. External single-nucleus data supported neuronal and oligodendrocyte patterns, while complementary analyses of purified microglia supported selected immune-cell findings. Integrative analyses of cleavage and polyadenylation factor expression, co-regulated usage networks, sequence motifs and published perturbations prioritized the cleavage factor Im complex as a candidate regulator. These findings identify cell-type-specific messenger RNA 3′-end remodeling as a reproducible dimension of Alzheimer’s disease molecular pathology that is only partly captured by gene-level analyses.
- 7 October 2026
- Published by Springer Nature in Research Square
Open AccessCell-type-resolved mRNA 3′-end remodeling in Alzheimer’s disease
Alternative polyadenylation diversifies messenger RNAs by altering coding sequences and 3′ untranslated regions, but its organization across human brain cell types and disruption in neurodegeneration remain poorly understood. By analyzing 3′-capture single-nucleus RNA sequencing data of 6.3 million nuclei from the prefrontal cortex of 1,494 human donors, we defined 108,768 polyadenylation sites across 25,274 genes, most of which were absent from the GENCODE polyadenylation-site annotation. Polyadenylation-site usage was strongly cell-type-specific and revealed regulatory differences not captured by gene expression. With increasing Alzheimer’s disease clinicopathological severity, excitatory neurons, oligodendrocytes and immune cells showed increased distal-site preference, including reduced relative usage of intronic sites and increased distal 3′ untranslated region usage in synaptic and RNA-processing genes. External single-nucleus data supported neuronal and oligodendrocyte patterns, while complementary analyses of purified microglia supported selected immune-cell findings. Integrative analyses of cleavage and polyadenylation factor expression, co-regulated usage networks, sequence motifs and published perturbations prioritized the cleavage factor Im complex as a candidate regulator. These findings identify cell-type-specific messenger RNA 3′-end remodeling as a reproducible dimension of Alzheimer’s disease molecular pathology that is only partly captured by gene-level analyses.
- Top Cited PapersOpen Access
- 23 September 2026
- Published by Springer Nature in Nature
- Vol. 657 (8133) , 988-1002
Single-cell atlas of transcriptomic vulnerability across brain disorders
Neurodegenerative and neuropsychiatric diseases impose a considerable societal and public health burden. However, our understanding of the molecular mechanisms underlying these highly complex conditions remains limited 1,2 . Here, to gain deeper insights into the aetiology of different brain diseases, we used specimens from 1,494 unique donors to generate a population-scale single-cell transcriptomic atlas of the human dorsolateral prefrontal cortex, comprising over 6.3 million individual nuclei. The cohort includes neurotypical controls, as well as donors affected by eight common and complex brain disorders: Alzheimer’s disease (AD), diffuse Lewy body disease (DLBD), vascular dementia (Vas), Parkinson’s disease (PD), tauopathy, frontotemporal dementia, schizophrenia, and bipolar disorder. We show that interindividual variation accounts for a substantial portion of gene expression variation. By comparing transcriptomic variation across diseases, we reveal universal signatures enriched in basic cellular functions such as mRNA processing and protein localization. After discounting these cross-disease signatures, we show stronger genetic and transcriptomic concordance among AD, DLBD, Vas and PD. Furthermore, we characterize transcriptomic variation among different AD phenotypes, distinct from those observed in healthy ageing, revealing a reduction in neuronal abundance in individuals with more severe AD, coupled with an increase in immune and vascular cell populations. Exploring the neuropsychiatric symptoms (NPSs) that frequently accompany AD, we find an increased abundance of deep-layer excitatory neurons associated with a broad range of NPSs. By constructing transcriptome trajectories that capture AD progression, we implicate cell-type-specific responses in the early and late stages of AD. Our disease atlas provides a perspective of the transcriptomic landscape in neurodegenerative and neuropsychiatric disorders, shedding light on shared and distinct processes involving the neurological–immune–vascular systems, and identifying potential targets for therapeutic intervention.
- 23 September 2026
- Published by Springer Nature in Nature
- Vol. 657 (8133) , 988-1002
Top Cited PapersOpen AccessSingle-cell atlas of transcriptomic vulnerability across brain disorders
Neurodegenerative and neuropsychiatric diseases impose a considerable societal and public health burden. However, our understanding of the molecular mechanisms underlying these highly complex conditions remains limited 1,2 . Here, to gain deeper insights into the aetiology of different brain diseases, we used specimens from 1,494 unique donors to generate a population-scale single-cell transcriptomic atlas of the human dorsolateral prefrontal cortex, comprising over 6.3 million individual nuclei. The cohort includes neurotypical controls, as well as donors affected by eight common and complex brain disorders: Alzheimer’s disease (AD), diffuse Lewy body disease (DLBD), vascular dementia (Vas), Parkinson’s disease (PD), tauopathy, frontotemporal dementia, schizophrenia, and bipolar disorder. We show that interindividual variation accounts for a substantial portion of gene expression variation. By comparing transcriptomic variation across diseases, we reveal universal signatures enriched in basic cellular functions such as mRNA processing and protein localization. After discounting these cross-disease signatures, we show stronger genetic and transcriptomic concordance among AD, DLBD, Vas and PD. Furthermore, we characterize transcriptomic variation among different AD phenotypes, distinct from those observed in healthy ageing, revealing a reduction in neuronal abundance in individuals with more severe AD, coupled with an increase in immune and vascular cell populations. Exploring the neuropsychiatric symptoms (NPSs) that frequently accompany AD, we find an increased abundance of deep-layer excitatory neurons associated with a broad range of NPSs. By constructing transcriptome trajectories that capture AD progression, we implicate cell-type-specific responses in the early and late stages of AD. Our disease atlas provides a perspective of the transcriptomic landscape in neurodegenerative and neuropsychiatric disorders, shedding light on shared and distinct processes involving the neurological–immune–vascular systems, and identifying potential targets for therapeutic intervention.
- 11 August 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (9) , 2152-2163
Plasticity of human microglia and brain perivascular macrophages in aging and Alzheimer’s disease
- 11 August 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (9) , 2152-2163
Plasticity of human microglia and brain perivascular macrophages in aging and Alzheimer’s disease
- 23 April 2024
- Published by Springer Nature in Nature Biotechnology
- Vol. 43 (2) , 214-222
Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening
T cell receptor (TCR) gene therapy is a potent form of cellular immunotherapy in which patient T cells are genetically engineered to express TCRs with defined tumor reactivity. However, the isolation of therapeutic TCRs is complicated by both the general scarcity of tumor-specific T cells among patient T cell repertoires and the patient-specific nature of T cell epitopes expressed on tumors. Here we describe a high-throughput, personalized TCR discovery pipeline that enables the assembly of complex synthetic TCR libraries in a one-pot reaction, followed by pooled expression in reporter T cells and functional genetic screening against patient-derived tumor or antigen-presenting cells. We applied the method to screen thousands of tumor-infiltrating lymphocyte (TIL)-derived TCRs from multiple patients and identified dozens of CD4+ and CD8+ T-cell-derived TCRs with potent tumor reactivity, including TCRs that recognized patient-specific neoantigens.
- 23 April 2024
- Published by Springer Nature in Nature Biotechnology
- Vol. 43 (2) , 214-222
Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening
T cell receptor (TCR) gene therapy is a potent form of cellular immunotherapy in which patient T cells are genetically engineered to express TCRs with defined tumor reactivity. However, the isolation of therapeutic TCRs is complicated by both the general scarcity of tumor-specific T cells among patient T cell repertoires and the patient-specific nature of T cell epitopes expressed on tumors. Here we describe a high-throughput, personalized TCR discovery pipeline that enables the assembly of complex synthetic TCR libraries in a one-pot reaction, followed by pooled expression in reporter T cells and functional genetic screening against patient-derived tumor or antigen-presenting cells. We applied the method to screen thousands of tumor-infiltrating lymphocyte (TIL)-derived TCRs from multiple patients and identified dozens of CD4+ and CD8+ T-cell-derived TCRs with potent tumor reactivity, including TCRs that recognized patient-specific neoantigens.
- Open Access
Plasticity of Human Microglia and Brain Perivascular Macrophages in Aging and Alzheimer’s Disease
The complex roles of myeloid cells, including microglia and perivascular macrophages, are central to the neurobiology of Alzheimer’s disease (AD), yet they remain incompletely understood. Here, we profiled 832,505 human myeloid cells from the prefrontal cortex of 1,607 unique donors covering the human lifespan and varying degrees of AD neuropathology. We delineated 13 transcriptionally distinct myeloid subtypes organized into 6 subclasses and identified AD-associated adaptive changes in myeloid cells over aging and disease progression. The GPNMB subtype, linked to phagocytosis, increased significantly with AD burden and correlated with polygenic AD risk scores. By organizing AD-risk genes into a regulatory hierarchy, we identified and validated MITF as an upstream transcriptional activator of GPNMB , critical for maintaining phagocytosis. Through cell-to-cell interaction networks, we prioritized APOE-SORL1 and APOE-TREM2 ligand-receptor pairs, associated with AD progression. In both human and mouse models, TREM2 deficiency disrupted GPNMB expansion and reduced phagocytic function, suggesting that GPNMB’s role in neuroprotection was TREM2 -dependent. Our findings clarify myeloid subtypes implicated in aging and AD, advancing the mechanistic understanding of their role in AD and aiding therapeutic discovery.
Open AccessPlasticity of Human Microglia and Brain Perivascular Macrophages in Aging and Alzheimer’s Disease
The complex roles of myeloid cells, including microglia and perivascular macrophages, are central to the neurobiology of Alzheimer’s disease (AD), yet they remain incompletely understood. Here, we profiled 832,505 human myeloid cells from the prefrontal cortex of 1,607 unique donors covering the human lifespan and varying degrees of AD neuropathology. We delineated 13 transcriptionally distinct myeloid subtypes organized into 6 subclasses and identified AD-associated adaptive changes in myeloid cells over aging and disease progression. The GPNMB subtype, linked to phagocytosis, increased significantly with AD burden and correlated with polygenic AD risk scores. By organizing AD-risk genes into a regulatory hierarchy, we identified and validated MITF as an upstream transcriptional activator of GPNMB , critical for maintaining phagocytosis. Through cell-to-cell interaction networks, we prioritized APOE-SORL1 and APOE-TREM2 ligand-receptor pairs, associated with AD progression. In both human and mouse models, TREM2 deficiency disrupted GPNMB expansion and reduced phagocytic function, suggesting that GPNMB’s role in neuroprotection was TREM2 -dependent. Our findings clarify myeloid subtypes implicated in aging and AD, advancing the mechanistic understanding of their role in AD and aiding therapeutic discovery.
- Open Access
- 1 April 2021
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-14
Adhering interacting cells to two opposing coverslips allows super-resolution imaging of cell-cell interfaces
Cell-cell interfaces convey mechanical and chemical information in multicellular systems. Microscopy has revealed intricate structure of such interfaces, yet typically with limited resolution due to diffraction and unfavourable orthogonal orientation of the interface to the coverslip. We present a simple and robust way to align cell-cell interfaces in parallel to the coverslip by adhering the interacting cells to two opposing coverslips. We demonstrate high-quality diffraction-limited and super-resolution imaging of interfaces (immune-synapses) between fixed and live CD8+ T-cells and either antigen presenting cells or melanoma cells. Imaging methods include bright-field, confocal, STED, dSTORM, SOFI, SRRF and large-scale tiled images. The low background, lack of aberrations and enhanced spatial stability of our method relative to existing cell-trapping techniques allow use of these methods. We expect that the simplicity and wide-compatibility of our approach will allow its wide dissemination for super-resolving the intricate structure and molecular organization in a variety of cell-cell interfaces.
- 1 April 2021
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-14
Open AccessAdhering interacting cells to two opposing coverslips allows super-resolution imaging of cell-cell interfaces
Cell-cell interfaces convey mechanical and chemical information in multicellular systems. Microscopy has revealed intricate structure of such interfaces, yet typically with limited resolution due to diffraction and unfavourable orthogonal orientation of the interface to the coverslip. We present a simple and robust way to align cell-cell interfaces in parallel to the coverslip by adhering the interacting cells to two opposing coverslips. We demonstrate high-quality diffraction-limited and super-resolution imaging of interfaces (immune-synapses) between fixed and live CD8+ T-cells and either antigen presenting cells or melanoma cells. Imaging methods include bright-field, confocal, STED, dSTORM, SOFI, SRRF and large-scale tiled images. The low background, lack of aberrations and enhanced spatial stability of our method relative to existing cell-trapping techniques allow use of these methods. We expect that the simplicity and wide-compatibility of our approach will allow its wide dissemination for super-resolving the intricate structure and molecular organization in a variety of cell-cell interfaces.
- Top Cited Papers
Genome-Scale Imaging of the 3D Organization and Transcriptional Activity of Chromatin
- Top Cited Papers
- 26 October 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 362 (6413) , 419-+
Super-resolution chromatin tracing reveals domains and cooperative interactions in single cells
Imaging chromatin spatial organization: The genome is organized within the nucleus as three-dimensional domains that modulate DNA-templated processes. Bintu et al. used high-throughput Oligopaint labeling and imaging to observe chromatin dynamics inside the nuclei of several different mammalian cell lines. After combining the datasets, single-cell matrices revealed chromatin arranged in topologically associating domains (TADs). Removing cohesin resulted in a loss of aggregate TADs among populations of cells, but specific TADs were still detected at the single-cell level. Furthermore, higher-order organization was detected, suggestive of cooperative interactions within the genome. Science , this issue p. eaau1783
- 26 October 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 362 (6413) , 419-+
Top Cited PapersSuper-resolution chromatin tracing reveals domains and cooperative interactions in single cells
Imaging chromatin spatial organization: The genome is organized within the nucleus as three-dimensional domains that modulate DNA-templated processes. Bintu et al. used high-throughput Oligopaint labeling and imaging to observe chromatin dynamics inside the nuclei of several different mammalian cell lines. After combining the datasets, single-cell matrices revealed chromatin arranged in topologically associating domains (TADs). Removing cohesin resulted in a loss of aggregate TADs among populations of cells, but specific TADs were still detected at the single-cell level. Furthermore, higher-order organization was detected, suggestive of cooperative interactions within the genome. Science , this issue p. eaau1783